CL2016002899A1 - Pyrrolidine-2,5-dione derivatives, pharmaceutical compositions and methods to use as inhibitors ido1 - Google Patents

Pyrrolidine-2,5-dione derivatives, pharmaceutical compositions and methods to use as inhibitors ido1

Info

Publication number
CL2016002899A1
CL2016002899A1 CL2016002899A CL2016002899A CL2016002899A1 CL 2016002899 A1 CL2016002899 A1 CL 2016002899A1 CL 2016002899 A CL2016002899 A CL 2016002899A CL 2016002899 A CL2016002899 A CL 2016002899A CL 2016002899 A1 CL2016002899 A1 CL 2016002899A1
Authority
CL
Chile
Prior art keywords
ido1
pyrrolidine
inhibitors
methods
pharmaceutical compositions
Prior art date
Application number
CL2016002899A
Other languages
Spanish (es)
Inventor
Stefano Crosignani
Sandra Cauwenberghs
Gregory Driessens
Frederik DEROOSE
Original Assignee
Iteos Therapeutics
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from BE2014/0754A external-priority patent/BE1021251B1/en
Application filed by Iteos Therapeutics filed Critical Iteos Therapeutics
Publication of CL2016002899A1 publication Critical patent/CL2016002899A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

<p>COMPUESTOS DERIVADOS DE PIRROLIDIN-2,5-DIONA;PROCEDIMIENTO DE PREPARACION; COMPOSICION FARMACEUTICA Y USO EN EL TRATAMIENTO DEL CANCER.</p><p> COMPOUNDS DERIVED FROM PIRROLIDIN-2,5-DIONA; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION AND USE IN THE TREATMENT OF CANCER. </p>

CL2016002899A 2014-05-15 2016-11-15 Pyrrolidine-2,5-dione derivatives, pharmaceutical compositions and methods to use as inhibitors ido1 CL2016002899A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461996976P 2014-05-15 2014-05-15
EP14168534 2014-05-15
BE2014/0754A BE1021251B1 (en) 2014-05-15 2014-10-21 PYRROLIDINE-2,5-DIONE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE AS INHIBITORS OF IDO1

Publications (1)

Publication Number Publication Date
CL2016002899A1 true CL2016002899A1 (en) 2017-06-02

Family

ID=59858293

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2016002899A CL2016002899A1 (en) 2014-05-15 2016-11-15 Pyrrolidine-2,5-dione derivatives, pharmaceutical compositions and methods to use as inhibitors ido1

Country Status (7)

Country Link
JP (1) JP2017214409A (en)
BR (1) BR112016026346A8 (en)
CL (1) CL2016002899A1 (en)
NI (1) NI201600171A (en)
PH (1) PH12016502281A1 (en)
SV (1) SV2016005317A (en)
ZA (1) ZA201607127B (en)

Also Published As

Publication number Publication date
ZA201607127B (en) 2018-05-30
PH12016502281A1 (en) 2017-02-13
BR112016026346A2 (en) 2017-08-15
JP2017214409A (en) 2017-12-07
NI201600171A (en) 2017-01-03
BR112016026346A8 (en) 2021-07-20
SV2016005317A (en) 2017-07-10

Similar Documents

Publication Publication Date Title
CU20160162A7 (en) DERIVATIVES OF PIRROLIDINA-2,5-DIONA, TO USE AS IDO1 INHIBITORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
CL2016003398A1 (en) Heteroaryl compounds useful as sumo activating enzyme inhibitors.
CL2016002027A1 (en) Cyclopropylamine as an inhibitor of lsd1
CL2015001985A1 (en) Thiazolcarboxamides and pyridinecarboxamide compounds, pim kinase inhibitors.
DOP2017000078A (en) INDAZOLS REPLACED WITH BENCILO AS INHIBITORS OF BUB1.
CL2016000807A1 (en) Amino heteroaryl benzamides as kinase inhibitors.
CL2016002269A1 (en) Allosteric modulators of the hepatitis core protein b.
NI201600144A (en) QUINOXALINE DERIVATIVES USEFUL AS MODULATORS OF FGFR KINASE
CL2016001933A1 (en) Compounds derived from macrocycles, inhibitors of the factor xia pharmaceutical composition that comprises them and their use in the treatment and prophylaxis of a thromboembolic disease. pct
CL2016000698A1 (en) Substituted quinolizine derivatives useful as hiv integrase inhibitors
EA201691988A1 (en) DERIVATIVES OF BORONIC ACID AND THEIR THERAPEUTIC APPLICATION
CL2015002767A1 (en) Therapeutic compounds and compositions
CL2015000829A1 (en) Histone Demethylase Inhibitors
CL2015002932A1 (en) Protein kinase inhibitors
EA201692301A1 (en) DERIVATIVES OF BORONIC ACID AND THEIR THERAPEUTIC APPLICATION
CL2016003422A1 (en) Lysine specific demethylase-1 inhibitors
CL2014002873A1 (en) Compounds derived from pyrimidin-amine or triazin-amine, adn-pk inhibitors; pharmaceutical composition; and its use for the treatment of cancer.
CL2012002189A1 (en) Compounds derived from substituted pyrrolidine-2-carboxamides; mdm2-p53 interaction inhibitors; pharmaceutical composition; and its use for the treatment of cancer, particularly solid tumors.
EA201591887A1 (en) MACROCYCLIC DEAZAOXIPURINS FOR THE TREATMENT OF VIRAL INFECTIONS
CL2016003423A1 (en) Lysine specific demethylase-1 inhibitors
CL2016001840A1 (en) Compounds derived from fused pyrimidines as inhibitors of the p97 complex; Pharmaceutical composition and use in cancer treatment.
CL2013000016A1 (en) Compounds derived from imidazopyridine; preparation procedure; Pharmaceutical composition and its use in the treatment of cancer.
CL2013001338A1 (en) Compounds derived from substituted benzothiene-pyridines, hiv replication inhibitors; pharmaceutical composition that includes them; pharmaceutical combination; pharmaceutical kit; and its use for the treatment of hiv.
EA201691845A1 (en) PHARMACEUTICAL COMPOSITIONS OF THERAPEUTICALLY ACTIVE COMPOUNDS
EA201591728A1 (en) HETEROCYCLIC COMPOUNDS AND METHODS OF THEIR APPLICATION